NCT02882282 2025-10-23Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial NeoplasiaM.D. Anderson Cancer CenterPhase 2 Completed15 enrolled 8 charts
NCT06998342 2025-05-31MOHSAHRTSSUniversity of Vermont Medical CenterPhase 2 Not yet recruiting24 enrolled